Biotech · Private company
CorMedix Therapeutics
Track this companyFree. Adds CorMedix Therapeutics to your Dealase workspace and tells you when its record changes.
Clinical trials32 recruiting or active
Pipeline programs5From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline5
- (taurolidine and heparin) catheter lock solutionPhase 3 · Central Line Associated Blood Stream Infections (CLABSI)ClinicalTrials.gov · fetched Nov 12, 2026
- HeparinPhase 3 · Central Line Associated Blood Stream Infections (CLABSI)ClinicalTrials.gov · fetched Nov 12, 2026
- HeparinPhase 3 · Kidney Failure, ChronicClinicalTrials.gov · fetched Nov 12, 2026
- NeutrolinPhase 3 · Kidney Failure, ChronicClinicalTrials.gov · fetched Nov 12, 2026
- (taurolidine and heparin) catheter lock solutionCatheter-Related InfectionsClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- Open-Label Study to Assess Safety and Time to Catheter-related Bloodstream Infections (CRBSI) in Subjects From Birth to < 18 Years of AgePHASE4 · RECRUITING · started Jul 8, 2025ClinicalTrials.gov NCT06714864 · fetched Nov 12, 2026
- Comparing The Safety And Efficacy Of DEFENCATH® In Reducing Central-Line Bloodstream Infections (CLABSIs) In Adults And Adolescent Participants Receiving Total Parenteral Nutrition Through A Central Venous Catheter (CVC)PHASE3 · RECRUITING · started May 14, 2025ClinicalTrials.gov NCT06822426 · fetched Nov 12, 2026
- Study Assessing Safety & Effectiveness of a Catheter Lock Solution in Dialysis Patients to Prevent Bloodstream InfectionPHASE3 · COMPLETED · started Dec 1, 2015ClinicalTrials.gov NCT02651428 · fetched Nov 12, 2026